This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: Centre Hospitalier Regional Universitaire De Brest, Centre National De La Recherche Scientifique, Institut Curie. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 5,383 
1 out of 162 
Years Active: 2022
Title: Claire Beauvineau: Innovator in Cancer Treatment
Introduction
Claire Beauvineau is a notable inventor based in Chilly Mazarin, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel compounds.
Latest Patents
Beauvineau holds a patent for "Hydrazone derivatives for preventing or treating EBV-related cancers." This invention relates to bis-hydrazone derivatives that are useful as drugs, particularly for treating or preventing cancers associated with the Epstein-Barr Virus. The patent describes compositions and kits that comprise these derivatives, which are defined by specific chemical formulas.
Career Highlights
Throughout her career, Claire Beauvineau has worked with prestigious institutions such as Institut Curie and Université Paris-Saclay. Her work has focused on developing therapeutic solutions that address critical health challenges.
Collaborations
Beauvineau has collaborated with esteemed colleagues, including Maria José Lista and Alicia Quillevere. These partnerships have enhanced her research and contributed to the advancement of her innovative projects.
Conclusion
Claire Beauvineau's contributions to cancer treatment through her patented inventions highlight her role as a leading innovator in the field. Her work continues to inspire advancements in medical research and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile